NewGenIvf Group Ltd
Business
NewGenIvf Group Ltd is a fertility treatment provider operating three clinics across Asia-Pacific (Thailand, Cambodia, Kyrgyzstan) that delivers in vitro fertilization (IVF) services, egg donation, and fertility referral services. The company generates revenue primarily from IVF treatment cycles and fertility referral commissions, leveraging proprietary and licensed reproductive technologies including MicroSort sperm sorting, preimplantation genetic screening (PGS), and next-generation sequencing. NewGenIvf targets fertility tourists from mainland China and Asia-Pacific seeking cost-effective comprehensive assisted reproductive services, with clinics staffed by experienced physicians, embryologists, and specialized medical teams.
Summary from 20-F filed 2026-03-31
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | $4.73M |
| Net income | $9.88M |
| Total assets | $32.72M |
| Total liabilities | $6.74M |
| Stockholders' equity | $26.63M |
| Operating cash flow | $-10.93M |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is NewGenIvf Group Ltd's CIK number?
NewGenIvf Group Ltd's SEC CIK number is 0001981662 (1981662). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find NewGenIvf Group Ltd's SEC filings?
All of NewGenIvf Group Ltd's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.